Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Ezetimibe Sandoz
Ezetimibe 10mg
Tablet
Novartis New Zealand Limited
Lek Pharmaceuticals d.d., Ljubljana, Slovenia
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Triumeq
Abacavir sulfate 702mg equivalent to Abacavir 600mg
Dolutegravir sodium 52.6mg equivalent to Dolutegravir 50mg
Lamivudine 300mg
Film coated tablet
GlaxoSmithKline (NZ) Limited
Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Hertfordshire, United Kingdom
|
Dated this 12th day of June 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz